Bartholomew J. Votta

机构：GlaxoSmithKline (United States)

发表论文 57 篇 · 总被引 6929 次 · h-index 30

代表论文

• Catalytic in vivo protein knockdown by small-molecule PROTACs (2015 · Nature Chemical Biology · 被引 1366)
• RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity (2014 · Molecular Cell · 被引 635)
• Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. (1996 · Journal of Pharmacology and Experimental Therapeutics · 被引 500)
• Inhibition of p38 MAP kinase as a therapeutic strategy (2000 · Immunopharmacology · 被引 459)
• N-((1 S)-1-{[4-((2 S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I (2008 · Journal of Pharmacology and Experimental Therapeutics · 被引 412)
• Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes (2009 · Arthritis & Rheumatism · 被引 312)